Scinovex
article Open Access

Clinical study for validation of safety and efficacy of Laooq Sapistan for symptomatic relief in Nazla (Common Cold)

Z. A. SiddiquiMohd. ArshadFasih AhmadMohd NaimeAmir -Jamal AkhtarMohd Nafees Khan

Abstract

Nazla, also known as acute viral rhinopharyngitis, nasopharyngitis, common cold, acute coryza, or just cold, is a viral infection of the upper respiratory tract that mostly affects the voice box, sinuses, throat, and nose. It is primarily caused by rhinoviruses and coronaviruses. The literature of Unani medicine describes Nazla-o-Zukām as a catarrhal fluid that flows from the anterior ventricles of the brain towards the throat and nose. A clinical study was conducted from 2016 to 2018 at the Central Research Institute of Unani Medicine (CRIUM), Basaha, Lucknow, to scientifically establish the safety and efficacy of the Unani pharmacopoeial formulation

Citations
1
FWCI
0.72
field-weighted impact
References
24
Percentile
70%
vs. same field & year
Cited by
Effect of compound Unani formulation for the treatment of constipation (Qabd): A case report
International Journal of Unani and Integrative Medicine · 2025 · 0 citations
References
Harrison's Principles of Internal Medicine.
Annals of Internal Medicine · 1988 · 12,587 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical study for validation of safety and efficacy of Laooq Sapistan for symptomatic relief in Nazla (Common Cold) · Scinovex